Medicines Discovery Catapult (MDC) exists to help reshape medicines discovery. It’s ambitious, and it’s achievable.
We do this by championing innovative life science technology and new approaches, supporting UK’s innovators to succeed. We thrive on innovation.
We collaborate with UK medicines discovery and diagnostics organisations, giving them access to industry-leading expertise, cutting-edge technology, and high-quality data. We accelerate their progress, precision drugs get to clinical trials more rapidly, and patients get life-improving medicines earlier than they otherwise would have.
If you’re involved with medicines discovery in the UK, MDC can almost certainly assist you. Our impact is measured by your success.
Medicines Discovery Catapult expands Biosamples supply network to support UK innovators, creating one of the world’s largest virtual biobanks
Today, Medicines Discovery Catapult (MDC) announce the rapid expansion of its Biosamples supply network, creating one of the largest virtual biobanks worldwide accessible to life
Medicines Discovery Catapult awarded funding to establish Cheshire & Warrington as an international powerhouse for the creation of new medicines
Today (11th August 2020), Medicines Discovery Catapult (MDC) announce that it has been awarded government seedcorn funding; provided through UK Research and Innovation’s flagship £236m
Cheshire East Council has welcomed the announcement on 4 August 2020, of £15.5 million of the Getting Building Fund for investment in schemes in Cheshire